• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP) in Can

  2026-05-03

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore PTEN function and robustly inhibit PI3K/Akt signaling in resistant cancer models. This article details practical workflows, experimental parameters, and troubleshooting strategies that leverage its uniquely stable, immune-evasive design.

• Isoprinosine: Applied Immunotherapy in Acute Viral Infection

  2026-05-02

  Isoprinosine (inosine pranobex) stands out as a dual-action immunomodulatory agent for acute respiratory viral infections, offering a reproducible edge in both viral inhibition and immune enhancement. This article bridges bench protocols, troubleshooting, and recent mechanistic advances—empowering researchers to optimize immunotherapy and antiviral workflows with confidence.

• Plant Exosome-like Nanovesicles Mitigate Testicular Injury v

  2026-05-02

  This study introduces Cistanche deserticola-derived exosome-like nanovesicles (CDELNs) as a novel intervention to alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The findings highlight the therapeutic potential of plant nanovesicles in male reproductive health and provide a mechanistic framework for further translational applications.

• Azithromycin and Roxithromycin: Repurposed Senolytics in Fib

  2026-05-01

  This study identifies azithromycin and roxithromycin, two macrolide antibiotics, as selective senolytic agents capable of efficiently eliminating senescent human fibroblasts. The findings reveal distinct metabolic and autophagic mechanisms underlying their activity and provide actionable insights for cellular senescence assay development and drug screening.

• Applied Workflows with Tetrandrine Alkaloid in Ion Channel S

  2026-04-30

  Tetrandrine alkaloid distinguishes itself as an indispensable tool in ion channel modulation and neuroscience research, offering robust DMSO solubility and validated performance. This guide details hands-on workflows, optimization strategies, and troubleshooting insights to unlock the full potential of Tetrandrine in advanced cell signaling and cancer biology experiments.

• AQP9 Downregulation Drives Proliferation in KRASG12V Colorec

  2026-04-30

  This study reveals that KRASG12V mutations in colorectal cancer are associated with reduced AQP9 expression, leading to increased tumor proliferation and decreased apoptosis. The findings clarify novel molecular links and highlight AQP9 as a potential therapeutic target, with implications for diagnostic and mechanistic research.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking Innov

  2026-04-29

  Explore the scientific advantages of EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) for advanced mRNA delivery and real-time intracellular imaging. This article unveils unique dual-reporter strategies and actionable assay insights for translational research.

• GPR107 Deficiency Drives Collagen IV Accumulation in Diabeti

  2026-04-29

  Xu et al. uncover how G protein-coupled receptor 107 (GPR107) loss exacerbates diabetic nephropathy by disrupting the endocytic regulation of collagen type IV in podocytes. Their mechanistic study links GPR107 to AT1R/Ca2+ signaling and highlights new therapeutic targets for renal fibrosis.

• Coumestrol Triggers Ferroptosis in RA Synoviocytes via PMAIP

  2026-04-28

  This study demonstrates that Coumestrol, a natural phytoestrogen, induces ferroptosis and suppresses inflammation in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) by stabilizing mitochondrial PMAIP1 through inhibition of TRIM3-mediated degradation. These findings highlight a novel mechanism with potential therapeutic implications for targeting synovial pathology in RA.

• Bafilomycin C1: Strategic V-ATPase Inhibition in Translation

  2026-04-28

  This thought-leadership article explores how Bafilomycin C1, a potent and selective vacuolar H+-ATPases inhibitor, empowers translational researchers to interrogate autophagy, intracellular pH regulation, and disease modeling. Integrating mechanistic insights, cutting-edge evidence from high-content cardiotoxicity screens, and strategic guidance, we outline best practices and competitive advantages for deploying Bafilomycin C1 in complex experimental settings. The discussion builds on APExBIO’s high-purity offering and advances the conversation beyond conventional product pages, providing a roadmap for rigorous, high-impact discovery.

• Multi-Omics Reveals ARID1A-Driven Resistance in Melanoma

  2026-04-27

  This study leverages integrative multi-omics to map dynamic resistance mechanisms in BRAF-mutant melanoma, spotlighting ARID1A loss as a key driver of transcriptional rewiring and immune evasion. The findings elucidate adaptive signaling shifts following MAPK/BRAF inhibition and highlight actionable network nodes for future therapeutic strategies.

• Shufeng Xingbi Therapy Modulates Th1/Th2 Balance and Gut Flo

  2026-04-27

  This study investigates the effect of Shufeng Xingbi Therapy (SFXBT) on Th1/Th2 immune balance and intestinal microbiota in a rat model of allergic rhinitis (AR). The findings highlight SFXBT's ability to improve immune regulation and gut microbiota composition, providing an experimental basis for integrative approaches to AR management.

• Mechanistic Insights into Diuron-Induced Acute Renal Injury

  2026-04-26

  This study integrates network toxicology, transcriptomic analysis, and experimental validation to reveal that Diuron induces acute kidney injury via activation of the JAK2/STAT1 pathway. These findings clarify the molecular mechanisms of Diuron nephrotoxicity and provide a foundation for improved environmental risk assessment and preventive research strategies.

• Luminescent ATP Cell Viability Assay Kit I: Precision for Fe

  2026-04-25

  The Luminescent ATP Cell Viability Assay Kit I empowers high-sensitivity, rapid cell viability measurement—crucial for dissecting regulated cell death such as ferroptosis. With streamlined, no-lysis workflow and robust luciferase luminescence detection, this APExBIO kit outperforms legacy methods in throughput, quantitation, and adaptability.

• GSK343 and Epigenetic Cancer Immunity: Precision Inhibition

  2026-04-24

  Explore how GSK343, a potent EZH2 inhibitor, advances epigenetic cancer research by precisely modulating histone H3K27 trimethylation. This article uniquely connects mechanistic insights to emerging immunoepigenetic strategies, offering researchers a new perspective on experimental design.

16939 records 1/1130 page Next 12345 下5页 Last page